These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38691647)

  • 1. iDose TR - a travoprost implant for glaucoma.
    Med Lett Drugs Ther; 2024 Apr; 66(1701):70-71. PubMed ID: 38691647
    [No Abstract]   [Full Text] [Related]  

  • 2. Durysta - a bimatoprost implant for glaucoma.
    Med Lett Drugs Ther; 2020 Jul; 62(1603):116-117. PubMed ID: 32728012
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of travoprost for the treatment of patients with glaucoma.
    Zhang XL; Qin L
    Medicine (Baltimore); 2019 Jul; 98(29):e16526. PubMed ID: 31335731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension.
    Dixon ER; Landry T; Venkataraman S; Gustafson N; Salem C; Bradfield Y; Aljasim LA; Feldman R
    J AAPOS; 2017 Oct; 21(5):370-374.e1. PubMed ID: 28887006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Latanoprost With Benzalkonium Chloride Versus Travoprost With SofZia on the Ocular Surface.
    Rahmatnejad K; Rapuano CJ; Ichhpujani P; Wizov SS; Moster MR; Hark LA; Katz LJ
    Eye Contact Lens; 2018 Nov; 44 Suppl 2():S93-S98. PubMed ID: 28617732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized crossover trial comparing effectiveness and tolerability of generic and brand-name travoprost.
    Ta Kim D; Daigle P; Carbonneau M
    Can J Ophthalmol; 2019 Apr; 54(2):223-228. PubMed ID: 30975346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension.
    Berdahl JP; Sarkisian SR; Ang RE; Doan LV; Kothe AC; Usner DW; Katz LJ; Navratil T;
    Drugs; 2024 Jan; 84(1):83-97. PubMed ID: 38060092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audible clicking on blinking: an adverse effect of topical prostaglandin analogue medication.
    Abedi F; Chappell A; Craig JE
    Clin Exp Ophthalmol; 2017 Apr; 45(3):304-306. PubMed ID: 27868329
    [No Abstract]   [Full Text] [Related]  

  • 10. Travoprost in children: adverse effects and intraocular pressure response.
    Yanovitch TL; Enyedi LB; Schotthoeffer EO; Freedman SF
    J AAPOS; 2009 Feb; 13(1):91-3. PubMed ID: 19233013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma.
    Naito T; Okuma S; Nagayama M; Mizoue S; Ozaki M; Namiguchi K; Miyamoto K; Tanito M; Yoshikawa K
    Adv Ther; 2016 Mar; 33(3):435-46. PubMed ID: 26861847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
    Eisenberg DL; Toris CB; Camras CB
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties.
    Ismail A; Nasr M; Sammour O
    Int J Pharm; 2020 Jun; 583():119402. PubMed ID: 32387308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
    Mishra D; Sinha BP; Kumar MS
    Korean J Ophthalmol; 2014 Oct; 28(5):399-407. PubMed ID: 25276082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability.
    Rossi GC; Scudeller L; Rolle T; Pasinetti GM; Bianchi PE
    Expert Opin Drug Saf; 2015 May; 14(5):619-23. PubMed ID: 25759110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
    King AJ; Rotchford AP
    JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of the Retina and Intrinsic Survival Signals in a Rat Model of Glaucoma following Brinzolamide and Travoprost Treatments.
    Park HY; Kim JH; Lee DE; Lee JH; Park CK
    Ophthalmic Res; 2011 Oct; 46(4):208-17. PubMed ID: 21464578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.
    Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV
    J Glaucoma; 2005 Oct; 14(5):392-9. PubMed ID: 16148589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma.
    Stahl E; Bremond-Gignac D; Landry T; Curtis M; Gedif K; Al Shahwan S; Dixon ER
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):361-365. PubMed ID: 28437175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.